CSF TAU biomarker-guided development of HSP90 inhibitors for alzheimer's disease

Ended Project Grant Awarded Last action

Award ID
R41AG042205
Recipient
Awarding agency
Obligated
$200,752

Award facts

Assistance listing
93.866 Aging Research
Completion date
Place of performance
Brookline, MA 02445, USA

Award details come from USAspending.gov.

Quick answers

Who received award R41AG042205?

R41AG042205 was awarded to Yuma Therapeutics Corporation by National Institutes of Health (Department of Health and Human Services) on September 1, 2012.

How much is award R41AG042205 worth?

$200,752 has been obligated on R41AG042205.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award